ホーム
マーケット
チャート&アイデア
Algo
ニュース
Store
ブローカー
ダウンロード
経済指標カレンダー
取引シグナル
Webターミナル
「
/
」を入力して検索:@user、$symbol
検索
ログイン
アカウントを作成
日本語
English
Русский
中文
Español
Português
Deutsch
한국어
Français
Italiano
Türkçe
LUCD
#3107
Lucid Diagnostics Inc. Common Stock
1.4
4
-2.04%
セクター:
ベース:
利益通貨:
日中レンジ
1年のレンジ
1日の変化
-2.04%
月次変化
+20.00%
6か月変化
+13.39%
1年の変化
-4.00%
以前の終値
1.4
7
Open
1.4
4
Bid
Ask
Low
1.4
4
High
1.4
4
ボリューム
32
マーケット
株
ヘルスケア
LUCD
Open full chart
Financials
Overview
明細書
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
37.43 M
43.39 M
48.24 M
90.75 M
—
Valuation ratios
Enterprise value
147.36 M
37.84 M
66.79 M
106.36 M
564.87 M
Price to earnings ratio
—
0.9
-1.1
-0.78
-4.34
Price to sales ratio
—
133.37
24.18
9.62
62.36
Price to cash flow ratio
—
1.69
1.77
0.94
6.17
Price to book ratio
—
2.18
-3.56
-0.84
-2.05
Enterprise value to EBITDA ratio
-5.38
-0.25
—
—
—
Profitability ratios
Return on assets %
0.48
1.73
1.93
1.48
1.51
Return on equity %
0.51
2.44
22.79
8.45
8.11
Return on invested capital %
4 002.77
2 672.42
877.18
662.87
630.4
Gross margin %
17
100
100
100
400
Operating margin %
5 483.8
14.9 K
2 020.08
1 070.98
4 564.52
EBITDA margin %
-5 483
-40.91 K
—
—
—
Net margin %
5 615.6
14.9 K
2 194.42
1 058.81
5 602.53
Liquidity ratios
Quick ratio
—
—
0.74
1.05
4.81
Current ratio
22.01
2.89
0.75
1.07
4.87
Inventory turnover
—
—
—
—
—
Asset turnover
0.01
0.01
0.08
0.15
0.13
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
0.51
0.61
2.68
Long term debt to total equity ratio
—
—
6.06
3.45
13.63
Per share metrics
Operating cash flow per share
—
0.82
0.79
0.87
0.58
EBIT per share
—
-4.32
—
—
—
EBITDA per share
—
-4.26
—
—
—
Total debt per share
—
—
—
—
—
Cash per share
—
0.62
0.45
0.44
1.56
Net current asset value per share
—
0.67
0.53
0.5
1.7
Tangible book value per share
—
0.54
-0.42
-0.99
-2.45
Working capital per share
—
0.44
-0.18
0.03
0.16
Book value per share
—
0.64
-0.39
-0.97
-2.42
ニュース
Teleflex (TFX) Q4 Earnings and Revenues Miss Estimates
Veracyte (VCYT) Q4 Earnings and Revenues Surpass Estimates
【決算速報】Lucid Diagnostics、売上高は予想を下回り、利益は予想を上回る結果に
Lucid Diagnostics earnings beat, revenue fell short of estimates
Orthofix (OFIX) Q4 Earnings and Revenues Lag Estimates
Inogen (INGN) Soars 6.6%: Is Further Upside Left in the Stock?
PAVmed raises $45 million, restructures capital to eliminate convertible debt
Lucid Diagnostics: Green Flags, But Dilution And Friction Keep Me Neutral (LUCD)
What's Going On With PAVmed Shares Thursday? - PAVmed (NASDAQ:PAVM)
ルシッド・ダイアグノスティクス株、がん検査のVA契約獲得で急騰
Lucid Diagnostics stock surges after securing VA contract for cancer test
Why Is PAVmed Stock Skyrocketing Wednesday? - Lucid Diagnostics (NASDAQ:LUCD), PAVmed (NASDAQ:PAVM)